(MENAFNEditorial) (ACN) – Ram Nath Kovind, president of India, expressed on Friday in this capital, his excellent impression on the Cuban biotechnology industry, after visiting the Center for Genetic Engineering and Biotechnology, as part of his work agenda in the island.
The president told Eduardo Martínez, president of the Group of Biotechnology and Pharmaceutical Industries (BioCubaFarma), that both nations will jointly provide a great service to humanity.
Martínez explained to Kovind that this industry emerged 35 years ago in the largest of the Antilles at the initiative of Commander in Chief Fidel Castro Ruz, and enjoys great international prestige.
He highlighted among its potentialities that adopts a closed cycle that covers the projection, research, production and marketing of products.
The president of BioCubaFarma mentioned some of the outstanding medicines of Cuba such as HeberFeron, Quimi-Hib, Heberbiovac HB, Heberprot-P, the latter with a gold medal granted by the World Intellectual Property Organization.
In addition, he indicated that the nation has more than 2,400 patents in the world and that it is currently working on several projects to deal with cardiovascular, brain, neurodegenerative and oncological conditions.
In an exchange with the press, Martínez stressed that this is a time to intensify the collaboration between the two States in that area and that in Cuba equipment produced in India has been used for several years.
He noted that on Thursday agreements were signed for the development of new products and the construction of plants to increase production capacity.
He also said that negotiations are underway for the possible creation of joint ventures in the Mariel Special Development Zone.
MENAFN2406201800704067ID1097064490
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.